A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential

@article{White2019ARO,
  title={A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential},
  author={C. Michael White},
  journal={The Journal of Clinical Pharmacology},
  year={2019},
  volume={59}
}
  • C. White
  • Published 1 July 2019
  • Medicine
  • The Journal of Clinical Pharmacology
Cannabidiol (CBD) is a highly touted product for many different disorders among the lay press. Numerous CBD products are available, ranging from a US Food and Drug Administration (FDA)‐approved product called Epidiolex to products created for medical marijuana dispensaries and products sold in smoke shops, convenience stores, and over the Internet. The legal status of the non–FDA‐approved products differs depending on the source of the CBD and the state, while the consistency and quality of the… 
Therapeutic Efficacy of Cannabidiol (CBD): a Review of the Evidence From Clinical Trials and Human Laboratory Studies
TLDR
Rigorous, controlled evidence for the therapeutic efficacy of CBD is lacking for many health conditions, including epilepsy, anxiety, pain/inflammation, schizophrenia, various substance use disorders, post-traumatic stress disorder, and others.
The Safety and Efficacy of CBD—A Pharmacist’s Perspective
TLDR
Different aspects of CBD use, including drug-drug interactions, drug toxicities, pharmacokinetics, and pharmacodynamic profiles of medications, and guideline-recommended therapeutic options are discussed from the point of view of a pharmacist.
The current understanding of the benefits, safety, and regulation of cannabidiol in consumer products.
The emerging role of cannabidiol (CBD) products; a survey exploring the public's use and perceptions of CBD
TLDR
The study highlighted that the public continue to seek natural alternatives to supplement and maintain their health; hence, the popularity of CBD continues to rise, and the lack of clinical evidence and regulation of CBD needs to be addressed to facilitate safe and effective use of CBD.
Cannabidiol: Science, Marketing, and Legal Perspectives
Recent loosening of legal restrictions on cannabis and its chemical constituents, including phytocannabinoids such as Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD), has led to rapid
Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements
TLDR
Owners and veterinarians wanting to utilize CBD-rich Cannabis sativa products should be aware of low-concentration products and should obtain a COA enabling them to fully discuss the implications of use and calculated dosing before administering to pets.
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
TLDR
Preliminary results from a recently completed controlled trial indicate that efficacy of CBD extends to the treatment of seizures associated with the tuberous sclerosis complex and to precipitation of some adverse effects, particularly somnolence.
CANNABIDIOL ( CBD ) AND THE ATHLETE : CLAIMS , EVIDENCE , PREVALENCE AND SAFETY CONCERNS
TLDR
Athletes should avoid the use of CBD and wait for further research into the efficacy and safety of supplementation, as the safety dataset of CBD is incomplete and known toxicities exist at pharmaceutical levels.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 65 REFERENCES
The Trouble with CBD Oil
  • A. Hazekamp
  • Medicine
    Medical Cannabis and Cannabinoids
  • 2018
TLDR
An overview paper looks into the known risks and issues related to the composition of CBD products, and makes recommendations for better regulatory control based on accurate labeling and more scientifically supported health claims.
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
TLDR
The often described favorable safety profile of CBD in humans was confirmed and extended by the reviewed research, and the most commonly reported side effects were tiredness, diarrhea, and changes of appetite/weight.
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
  • E. Perucca
  • Medicine, Psychology
    Journal of epilepsy research
  • 2017
TLDR
There is now class 1 evidence that adjunctive use of CBD improves seizure control in patients with specific epilepsy syndromes, for the first time, according to currently available information.
Safety and Pharmacokinetics of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl in Humans
TLDR
Cannabidiol does not exacerbate adverse effects associated with intravenous fentanyl administration and these data provide the foundation for future studies examining CBD as a potential treatment for opioid abuse.
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers.
TLDR
In healthy volunteers, THC has marked acute behavioural and physiological effects, whereas CBD has proven to be safe and well tolerated.
Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview
TLDR
Current evidences suggest that CBD has the ability to reduce psychotic, anxiety and withdrawal symptoms by means of several hypothesised pharmacological properties, however, further studies should include larger randomised controlled samples and investigate the impact of CBD on biological measures in order to correlate CBD's clinical effects to potential modifications of neurotransmitters signalling and structural and functional cerebral changes.
Action of cannabidiol on the anxiety and other effects produced by δ9-THC in normal subjects
TLDR
It was verified that CBD blocks the anxiety provoked by Δ9-TCH, however this effect also extended to marihuanalike effects and to other subjective alterations induced by Δ 9-T CH, and the effects of CBD might be involved in the antagonism of effects between the two cannabinoids.
Effects of Cannabidiol (CBD) on Regional Cerebral Blood Flow
TLDR
The results suggest that CBD has anxiolytic properties, and that these effects are mediated by an action on limbic and paralimbic brain areas.
...
1
2
3
4
5
...